NCT02913196 2026-04-20
Phase I Trial of Apalutamide Plus Abiraterone Acetate, Docetaxel, and Prednisone in Patients With mCRPC
Weill Medical College of Cornell University
Phase 1 Completed
Clinical Trials
5 trialsNCT06320067 2025-09-26
STAMPEDE2
University College, London
Phase 3 Recruiting
NCT04028388 2024-04-17
ModraDoc006/r vs Docetaxel IV in Metastatic Prostate Cancer
Modra Pharmaceuticals
Phase 2 Completed
NCT04603833 2021-02-21
A Study of SHR3680 in Combination With Docetaxel in the Treatment of mCRPC
Jiangsu HengRui Medicine Co., Ltd.
Phase 2 Unknown
NCT01718353 2017-11-20
TAXYNERGY
Sanofi
Phase 2 Completed